References
- 1. Siegel, R.M., Frederiksen, J.K., Zacharias, D.A., Chan, F.K., Johnson, M., Lynch, D., Tsien, R.Y., Lenardo, M.J. (2000). Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288(5475): 2354-2357. https://doi.org/10.1126/science.288.5475.2354 PMid:1087591810875918
- 2. Chan, F.K., Chun, H.J., Zheng, L., Siegel, R.M., Bui, K.L., Lenardo, M.J. (2000). A domain in TNF receptors that mediates ligand-independent recpetor assembly and signaling. Science 288(5475): 2351-2354. https://doi.org/10.1126/science.288.5475.2351 PMid:1087591710875917
- 3. Cooperberg, M.R., Park, S., Carroll, P.R. (2004). Prostate cancer 2004: insights from national disease registries. Oncology (Williston Park) 18(10): 1239-1247.
- 4. Sun, Y., Niu, J., Huang, J. (2009). Neuroendocrine differentiation in prostate cancer. Am J Transl Res. 1(2): 148-162.
- 5. Vashchenko, N., Abrahamsson, P.A. (2005). Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities. Eur Urol. 47(2): 147-155. https://doi.org/10.1016/j.eururo.2004.09.007 PMid:1566140815661408
- 6. Bonkhoff, H. (2001). Neuroendocrine differentiation in human prostate cancer. Mor phogenesis, proliferation and androgen receptor status. Ann Oncol. 12 (Suppl 2): S141-S144. https://doi.org/10.1093/annonc/12.suppl_2.S141 PMid:11762342
- 7. Huang, J., Yao, J.L., di Sant’agnese, P.A., Yang, Q., Bourne, P.A., Na, Y. (2006). Immunohistochemical characterization of neuroendocrine cells in prostate cancer. Prostate 66(13): 1399-1406. https://doi.org/10.1002/pros.20434 PMid:1686572616865726
- 8. Sambrook, J., Fritsch, E.F., Maniatis, T. (1989). Molecular cloning: a laboratory manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
- 9. Panov, S. (2003). Basic methods in molecular biology. Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University in Skopje.
- 10. Panov, S. (2005). The effects of the RNA interference-mediated silencing of bcl-2 and hTERT genes in lung cancer cell lines [dissertation]. [Skopje, Macedonia]: Faculty of Natural Sciences and Mathematics, 147 p.
- 11. Wigler, M., Pellicer, A., Silverstein, S., Axel, R., Urlaub, G., Chasin, L. (1979). DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci USA. 76(3): 1373-1376. https://doi.org/10.1073/pnas.76.3.1373 PMid:286319 PMCid:PMC383253383253286319
- 12. Floch, V., Le Bolc’h, G., Audrezet, M.P., Yaouanc, J.J., Clement, J.C., des Abbayes, H., Mercier, B., et al. (1997). Cationic phosphonolipids as non viral vectors for DNA transfection in hematopoietic cell lines and CD34+ cells. Blood Cells Mol Dis. 23(1): 69-87. https://doi.org/10.1006/bcmd.1997.0123 PMid:92157529215752
- 13. Guillaume-Gable, C., Floch, V., Mercier, B., Audrezet, M.P., Gobin, E., Le Bolch, G., Yaouanc, J.J., et al. (1998). Cationic phosphonolipids as nonviral gene transfer agents in the lungs of mice. Hum Gene Ther. 9(16): 2309-2319. https://doi.org/10.1089/hum.1998.9.16-2309 PMid:98295309829530
- 14. Izumi, M., Miyazawa, H., Kamakura, T., Yamaguchi, I., Endo, T., Hanaoka, F. (1991). Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. Exp Cell Res. 197(2): 229-233. https://doi.org/10.1016/0014-4827(91)90427-V1720391
- 15. Lin, Y., Ma, W., Benchimol, S. (2000). Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet. 26(1): 122-127. https://doi.org/10.1038/79102 PMid:1097326410973264
- 16. Osmak, M., Kapitanovic, S., Vrhovec, I., Beketic-Oreskovic, L., Jer nej, B., Eljuga, D., Skrk, J. (1997). Characterization of human breast adenocarcinoma SK-BR-3 cells resistant to doxorubicin. Neoplasma 44(3): 157-162.
- 17. Osmak, M., Brozovic, A., Ambriovic-Ristov, A., Hadzija, M., Pivcevic, B., Smital, T. (1998). Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cells. Neoplasma 45(4): 223-230.
- 18. Osmak, M., Bordukalo, T., Kosmrlj, J., Kvajo, M., Marijanovic, Z., Eljuga, D., Polanc, S. (1999). Diazenes: modificators of tumor cell resistance to cisplatin. Neoplasma. 46(4): 201-206.
- 19. Bishop, J.M., Weinberg, R.A. (1996). Molecular oncology. New York: Scientific American, Inc.
- 20. Panasci, M., Ballard, B.W., Breck, S., Rodriguez, D., Densimore, D.L. III, Weester, D.B., Baker, J.R. (2011). Evaluation of fecal DNA preservation techniques and effects of sample age and diet on genotyping success. J Wildl Manage. 75(7): 1616-1624. https://doi.org/10.1002/jwmg.221
- 21. Hanahan, D., Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100(1): 57-70. https://doi.org/10.1016/S0092-8674(00)81683-910647931
- 22. Kramer, G., Erdal, H., Mertens, H.J., Nap, M., Mauermann, J., Steiner, G., Marberger, M., et al. (2004). Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18”. Cancer Res 64(5): 1751-1756. https://doi.org/10.1158/0008-5472.CAN-03-2455 PMid:14996736
- 23. Degterev, A., Lugovskoy. A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., Yuan, J. (2001). Identification of small molecule inhibitors of interaction between the BH3 domain and BCL-XL. Nat Cell Biol. 3(2): 173-182. https://doi.org/10.1038/35055085 PMid:1117575011175750
- 24. Brummelkamp, T.R., Bernards, R., Agami, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296(5567): 550-553. https://doi.org/10.1126/science.1068999 PMid:1191007211910072
- 25. Cao, W., Shiverick, K.T., Namiki, K., Sakai, Y., Porvasnik, S., Urbanek, C., Rosser, C.J. (2008). Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation. World J Urol. 26(5): 509-516. https://doi.org/10.1007/s00345-008-0289-5 PMid:1859482918594829
- 26. Cheng, T.L., Teng, C.F., Tsai, W.H., Yeh, C.W., Wu, M.P., Hsu, H.C., Hung, C.F., Chang, W.T. (2009). Multitarget therapy of malignant cancers by the head-to-tail tandem array multiple shRNAs expression systemA multiple shRNAs-based gene therapy, Cancer Gene Ther. 16(6): 516-531. https://doi.org/10.1038/cgt.2008.102 PMid:1916523419165234
- 27. Pulukuri, S.M.K., Gondi, C.S., Lak ka, S.S., Jutla, A., Estes, N., Gujrati, M., Rao, J.S. RNA Interference-directed knockdown of urokinase plasminogen activator and urokinase Plasminogen activator receptor inhibits prostatecancer cell invasion, survival and tumorogenesis in vivo. J Biol Chem. 280(43): 36529-36540. https://doi.org/10.1074/jbc.M503111200 PMid:16127174 PMCid:PMC1351057135105716127174
- 28. Jia, J., Zhang, W., Wang, B., Trinko, R., Jiang, J. (2003). The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 17(20): 2514-2519. https://doi.org/10.1101/gad.1134003 PMid:14561774 PMCid:PMC21814521814514561774